Nouri Fatemeh, Nematollahi-Mahani Seyed Noureddin, Sharifi Ali Mohammad
Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.
Department of Anatomy, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
Adv Pharm Bull. 2019 Feb;9(1):76-83. doi: 10.15171/apb.2019.010. Epub 2019 Feb 21.
To investigate the protective effect of preconditioning with non-toxic dose of hydrogen peroxide (HO) as a possible cell signaling molecule, against cell death induced by toxic concentration of HO or by serum deprivation in human Wharton's jelly-derived mesenchymal stem cells (HWJ-MSCs) and underlying mechanisms. HWJ-MSCs were isolated and identified using flow cytometry. After finding non-toxic concentration of HO, cells preconditioning was performed by HO (20 μM) for 12 h and cell tolerance against serum deprivation or toxic levels of HO was assayed by MTT test. Effect of preconditioning on mRNA and protein expression of Akt-1, Bcl-2 and Bax were examined using reverse transcription polymerase chain reaction (RT-PCR) and western blotting respectively. Role of hypoxia-inducible factor (HIF)-1α was explored in presence HIF-1α inhibitor. Preconditioning with 20 μM HO for 12 h was non-toxic and decreased cell death induced by oxidative stress and serum deprivation in MSC cultures. However, the increased tolerance reversed in the presence of inhibitor of HIF-1α. By regards to RT-PCR and western blotting data, although expression of Akt-1, Bcl-2 and Bax was not change considerably but phosphorylated Akt-1 (pAkt-1) was up regulated after treatment with 20 μM HO compared to control group. Moreover after exposure to 100 μM HO, western blotting analysis showed that cell pretreatment with 20 μM HO, decremented Bax/Bcl2 ratio and up-regulated HIF-1α and pAkt-1 compared to the control group. Increased tolerance of HO-pretreated cells led to the suggestion that transplantation of HO preconditioned MSCs may improve therapeutic potential of stem cells in cell therapy procedures.
为研究无毒剂量的过氧化氢(HO)作为一种可能的细胞信号分子进行预处理,对人脐带华通氏胶间充质干细胞(HWJ-MSCs)中由有毒浓度的HO或血清剥夺诱导的细胞死亡的保护作用及其潜在机制。使用流式细胞术分离并鉴定HWJ-MSCs。在确定HO的无毒浓度后,用HO(20μM)对细胞进行12小时预处理,并通过MTT试验检测细胞对血清剥夺或HO毒性水平的耐受性。分别使用逆转录聚合酶链反应(RT-PCR)和蛋白质印迹法检测预处理对Akt-1、Bcl-2和Bax的mRNA和蛋白质表达的影响。在存在缺氧诱导因子(HIF)-1α抑制剂的情况下探讨HIF-1α的作用。用20μM HO预处理12小时无毒,并减少了MSC培养物中由氧化应激和血清剥夺诱导的细胞死亡。然而,在存在HIF-1α抑制剂的情况下,增加的耐受性被逆转。关于RT-PCR和蛋白质印迹数据,虽然Akt-1、Bcl-2和Bax的表达没有明显变化,但与对照组相比,用20μM HO处理后磷酸化的Akt-1(pAkt-1)上调。此外,在暴露于100μM HO后,蛋白质印迹分析表明,与对照组相比,用20μM HO对细胞进行预处理可降低Bax/Bcl2比率,并上调HIF-1α和pAkt-1。HO预处理细胞耐受性的增加表明,HO预处理的MSCs移植可能会提高干细胞在细胞治疗程序中的治疗潜力。